Infographic| Volume 37, ISSUE 9, P2732-2734, September 2021

Platelet-Rich Plasma: Fundamentals and Clinical Applications


      Platelet-rich plasma (PRP) is perhaps the most widely studied of the biologic therapies, with an ever-growing body of evidence supporting its safety and efficacy in decreasing inflammation and pain and promoting healing in the setting of both nonoperative and operative treatments. PRP is produced by the centrifugation of whole blood, isolating its constituent parts based on their unique densities. These density gradients can be selectively harvested so as to obtain different concentrations of various blood product components, such as platelets and leukocytes. A precise and consistent method for describing the essential characteristics of different PRP formulations is critical for both practical and research purposes. The concentration of platelets, method of activation, and the total number of red blood cells (RBCs), white blood cells (WBCs), and neutrophils relative to baseline values are all of particular importance in accurately describing a PRP formulation. The biologic activity of PRP is manifold: platelet α granules promote the release of various growth factors, including vascular endothelial growth factor and tissue growth factor β, while inflammation is modulated through inhibition of the nuclear factor-κB pathway. PRP has been convincingly shown to be efficacious in the setting of patellar tendinopathies, knee osteoarthritis, and lateral epicondylitis. In fact, several recent randomized controlled trials have demonstrated the superiority of PRP over both corticosteroids and hyaluronic acid in treating knee OA-related symptoms. There is also substantial promise for the utility of PRP in treating partial hamstring tears and as an adjunct to rotator cuff (RC) repair, especially in the setting of small- to medium-sized tears, where it appears to exert substantial analgesic effects and promote enhanced rates of RC repair healing.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Arthroscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Anz A.W.
        • Parsa R.S.
        • Romero-Creel M.F.
        • et al.
        Exercise-mobilized platelet-rich plasma: Short-term exercise increases stem cell and platelet concentrations in platelet-rich plasma.
        Arthroscopy. 2019; 35: 192-200
        • Bendinelli P.
        • Matteucci E.
        • Dogliotti G.
        • et al.
        Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: Mechanisms of NF-κB inhibition via HGF.
        J Cell Physiol. 2010; 225: 757-766
        • Boswell S.G.
        • Cole B.J.
        • Sundman E.A.
        • Karas V.
        • Fortier L.A.
        Platelet-rich plasma: A milieu of bioactive factors.
        Arthroscopy. 2012; 28: 429-439
        • Bradley J.P.
        • Lawyer T.J.
        • Ruef S.
        • Towers J.D.
        • Arner J.W.
        Platelet-rich plasma shortens return to play in National Football League players with acute hamstring injuries.
        Orthop J Sports Med. 2020; 8 (2325967120911731)
        • Cole B.J.
        • Karas V.
        • Hussey K.
        • Pilz K.
        • Fortier L.A.
        Hyaluronic acid versus platelet-rich plasma: A prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis.
        Am J Sports Med. 2017; 45: 339-346
        • Cross J.A.
        • Cole B.J.
        • Spatny K.P.
        • et al.
        Leukocyte-reduced platelet-rich plasma normalizes matrix metabolism in torn human rotator cuff tendons.
        Am J Sports Med. 2015; 43: 2898-2906
        • DeLong J.M.
        • Russell R.P.
        • Mazzocca A.D.
        Platelet-rich plasma: The PAW classification system.
        Arthroscopy. 2012; 28: 998-1009
        • Hurley E.T.
        • Lim Fat D.
        • Moran C.J.
        • Mullett H.
        The efficacy of platelet-rich plasma and platelet-rich fibrin in arthroscopic rotator cuff repair: A meta-analysis of randomized controlled trials.
        Am J Sports Med. 2019; 47: 753-761
        • Hurley E.T.
        • Colasanti C.A.
        • Anil U.
        • et al.
        The effect of platelet-rich plasma leukocyte concentration on arthroscopic rotator cuff repair: A network meta-analysis of randomized controlled trials.
        Am J Sports Med. 2020; (363546520975435)
        • Lamplot J.D.
        • Rodeo S.A.
        • Brophy R.H.
        A practical guide for the current use of biologic therapies in sports medicine.
        Am J Sports Med. 2020; 48: 488-503
        • Mishra A.K.
        • Skrepnik N.V.
        • Edwards S.G.
        • et al.
        Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients.
        Am J Sports Med. 2014; 42: 463-471
        • Murray I.R.
        • Geeslin A.G.
        • Goudie E.B.
        • Petrigliano F.A.
        • LaPrade R.F.
        Minimum information for studies evaluating biologics in orthopaedics (MIBO): Platelet-rich plasma and mesenchymal stem cells.
        J Bone Joint Surg Am. 2017; 99: 809-819
        • Park Y.B.
        • Kim J.H.
        • Ha C.W.
        • Lee D.H.
        Clinical efficacy of platelet-rich plasma injection and its association with growth factors in the treatment of mild to moderate knee osteoarthritis: A randomized double-blind controlled clinical trial as compared with hyaluronic acid.
        Am J Sports Med. 2021; 49: 487-496
        • Scott A.
        • LaPrade R.F.
        • Harmon K.G.
        • et al.
        Platelet-rich plasma for patellar tendinopathy: A randomized controlled trial of leukocyte-rich PRP or leukocyte-poor PRP versus saline.
        Am J Sports Med. 2019; 47: 1654-1661
        • Sundman E.A.
        • Cole B.J.
        • Karas V.
        • et al.
        The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis.
        Am J Sports Med. 2014; 42: 35-41